Introduction
In the general population, vitamin D deficiency, assessed by low levels of 25-hydroxy vitamin D (25(OH)D), has been associated with diverse conditions, of which many have become of concern in the HIV-infected population, such as infections, cardiovascular disease, insulin resistance and diabetes, dyslipidemia, cancer, neurocognitive impairment, frailty, renal function alteration, osteopenia/osteoporosis, and autoimmune diseases [1] [2] [3] [4] . It has also been associated with all-cause and cardiovascular mortality in persons weakened by age [5] or chronic conditions such as high cardiovascular risk [6] , diabetes [7] , cancer [8] , heart transplantation [9] and renal failure [10] .
Studies in HIV-infected persons, mostly antiretroviral-treated, showed that vitamin D deficiency is not more prevalent than in the general population [11, 12] . However, besides factors usually associated with vitamin D deficiency (e.g. phototype, season, region), HIV disease parameters such as a low CD4 count and exposure to antiretrovirals have been associated with low 25(OH)D levels [11] . Whatever the causes of lowered 25(OH)D in HIV-infected persons, the known associations of vitamin D deficiency with inflammation [13, 14] , activation of coagulation [15] , and impaired T-cell function [16] makes it a plausible cofactor in the pathogenesis of clinical complications and comorbidities of HIV infection. Indeed, vitamin D deficiency has been associated with clinical and pre-clinical endpoints in HIV-infected persons: all-cause mortality during untreated [17] and treated [18, 19] HIV infection, lesser CD4 cell gain on antiretroviral therapy [20, 21] , AIDS and non-AIDS-defining events [18, 22, 23] , insulin resistance [24] , type 2 diabetes [25] , and atherosclerosis [26] [27] [28] . Altogether, these data suggest that treated and untreated HIV-infected persons might be particularly susceptible to the deleterious effects of vitamin D deficiency.
The interpretation of studies in treated patients is hampered by the effects of antiretroviral drugs, their metabolic adverse events, and their possible impact on vitamin D metabolism [11] . The present study investigated for the first time the associations between 25(OH)D levels and body composition, metabolic, immunologic and inflammatory markers in a large group of White and Black antiretroviral-naïve HIV-1-infected persons enrolled soon after HIV diagnosis.
Methods

Study Design
The ANRS-C09-COPANA cohort is an ongoing prospective study conducted in 37 hospitals in France. Between 2004 and 2008, it enrolled 800 recently diagnosed (,1 year) HIV-1-infected adults, antiretroviral naïve at baseline, with semi-annual follow-up. The Paris-Cochin Ethics Committee approved the study protocol and all participants gave written informed consent. At enrollment and each scheduled visit, detailed sociodemographic, clinical and biological data were collected. Patients who accepted to participate entered a metabolic substudy comprising an oral glucose tolerance test (OGTT), measurements of inflammatory markers, insulin and adipokines, computed tomography (CT) at the level of the L4 vertebra and dual-energy X-ray absorptiometry (DEXA) [29] . 25(OH)D was measured in plasma samples taken at enrollment from 355 patients of Black or White ethnicity (patients in the metabolic study and patients selected for a longitudinal study on the basis of remaining treatment-naïve at 1 year of follow-up).
Measurements
Age, gender, ethnicity, smoking, alcohol consumption, HIV transmission category, blood pressure, height, weight, body mass index (BMI) and waist circumference were documented at enrollment. CD4 cell count, HIV RNA viral load, blood levels of fasting lipids, glucose and creatinine, were measured at each center with standard procedures. The MDRD equation was used for calculation of the estimated glomerular filtration rate (eGFR). 25(OH)D was measured on cryopreserved plasma samples at Necker Hospital, Paris, using the DiaSorinH radioimmunassay. Sampling season was defined as summer/autumn for patients sampled in June -November, and as winter/spring for those sampled in December -May.In patients enrolled in the metabolic substudy, glycemia and insulinemia were measured at T0 and T120 minutes of an OGTT (75 g of glucose) performed after at least 8-hour fast. Inflammatory markers, insulin and adipokines levels were measured on cryopreserved serum samples at Tenon Hospital, Paris. Insulin was measured with a method avoiding cross-reactivity with pro-insulin (ARCHITECT system; Abbott, North Chicago, IL USA The analysis performed within the EuroSIDA study showed that increased risks of AIDS-defining events and all-cause death were associated with very low 25(OH)D levels, ,12 ng/mL, which is very close to the commonly accepted definition of severe deficiency (,10 ng/mL) [18] . We therefore decided to classify patients into 2 categories according to severely deficient status (25(OH)D,10 ng/mL and $10 ng/mL). We also classified patients according to deficient status (25(OH)D,20 ng/mL and $20 ng/mL).
Associations between 25(OH)D severely deficient or deficient status and socio-demographic characteristics, immuno-virologic, inflammatory and metabolic markers were explored using logistic regression models; P-values were estimated by the Wald tests, and analyses were systematically adjusted for season, ethnicity and season-ethnicity interaction. Multivariate analysis was performed by logistic regression. All variables associated with severe vitamin D deficiency with a P value#0.10 after adjustment for season, ethnicity and season-ethnicity interaction were included in the initial model, except visceral adipose tissue measurement due to the statistical power issue. Backward stepwise selection process of variables with P,0.10 was used to determine the final multivariate logistic model; season, ethnicity and season-ethnicity interaction were forced into the model.
We further explored whether the association between severe immunodeficiency and low levels of 25(OH)D could be explained by increased levels of inflammatory markers. To do so, we used a multivariate logistic model assessing the association between severe immune deficiency (as the dependent variable) with severe vitamin D deficiency and inflammatory markers. Several models were built, one per inflammatory marker.
Statistical analyses were performed using SAS software version 9.2 (SAS Institute, Cary, NC, USA).
Results
Baseline Characteristics
Among the 355 patients, 108 (30%) were women and 150 (42%) were men having sex with men (MSM), 97% of patients having been infected by the sexual route. At enrollment, median age was 36 years (IQR: 30-44) and median BMI was 23.0 kg/m 2 (IQR: 20.8-25.7). Median duration since HIV diagnosis was 3.8 months (IQR: 1.5-7.1), median HIV-1 RNA level was 4.6 log 10 copies/ mL (IQR: 4.1-5.2), median CD4+ T-cell count was 300/mm 3 (IQR: 173-463) and 34 patients (9.6%) were at CDC stage C of infection. 151 (43%) patients were Black (134 of African and 17 of Afro-Caribbean origin). Compared to Whites, Black patients were younger (median age: 34 vs. 37 years, P = 0.03), more often female (55% vs. 12%, P,0.001) or heterosexual men (70% vs. 24% of the men, P,0.001), they had a higher BMI (median: 23.9 vs. 22.5, P,0.001) and their median CD4+ T-cell count was lower (245 vs. 344/mm 3 , P,0.001).
Low 25(OH)D Concentrations in Antiretroviral-naïve, Recently Diagnosed HIV-infected Patients
A vast majority of the patients (93%) had vitamin D insufficiency, i.e. 25(OH)D,30 ng/mL. Criteria for vitamin D deficiency (,20 ng/mL) or severe deficiency (,10 ng/mL) were met by 67 and 24% of the patients, respectively.
Patients sampled in winter/spring had a much lower 25(OH)D level than those sampled in summer/autumn: median of 13 ng/ mL (IQR: 9-19.5) vs. 18 ng/mL (IQR: 12-24) (P,0.001). Median 25(OH)D was significantly lower in Black than in White patients, even after adjustment for age, sex, sampling season and BMI: adjusted mean 13.9 ng/mL (95%CI: 12.5-15.3) in Blacks vs. 18.7 ng/mL (95%CI:17.3-20.1) in Whites, (P,0.001).
As illustrated by figure 1, season's impact on 25(OH)D plasma concentrations was markedly less pronounced in Black than in White patients. In a linear regression model, season (P,0.001), ethnicity (P,0.001) and the interaction between season and ethnicity (P,0.01) were significantly associated with 25(OH)D levels. Indeed, the difference in means between the seasons was 6.4 in Whites vs. 2.2 ng/mL in Blacks. This difference remained significant after taking into account the residence zone (South vs.
North of France).
Association between Severe Vitamin D Deficiency, Clinical Characteristics and Biomarkers (Table 1) Tobacco smokers and persons drinking more than 20 g of alcohol a day were significantly overrepresented among patients with severe vitamin D deficiency. The same trend, not reaching statistical significance (P = 0.08), was noted for non-MSM, compared with MSM.
Patients with 25(OH)D concentrations below 10 ng/mL had a more severe immune deficiency than patients with 25(OH)D$10 ng/mL, since 18.8% vs. 10.7% had a CD4 count,100/mm 3 (P = 0.04). They also had higher levels of the inflammatory markers hsCRP ( ) and severe vitamin D deficiency by testing different models comprising vitamin D (,10 ng/mL vs. $10 ng/mL) and several inflammatory markers. After adjustment for either hsCRP, sTNFR1 or sTNFR2, the significance and magnitude of the association between severe vitamin D deficiency and having a CD4 count,100/mm 3 were reduced ( Table 2 ), suggesting that these markers could in part explain this association. On the other hand, adjustment for resistin, IL-6, MCP-1 and TNF-a did not weaken the relationship between vitamin D deficiency and low CD4 counts. 
Longitudinal Study
Values of inflammatory and metabolic markers were available at one year of follow-up in a subgroup of 53 patients who remained antiretroviral-naïve. Patients with 25(OH)D ,10 ng/ mL at inclusion had higher levels of sTNFR1 and tended to have higher levels of hsCRP one year later than the other patients: 
Discussion
We show herein that severe vitamin D deficiency is associated with very low CD4 counts (,100/mm 3 ) and inflammation in untreated HIV infection. HIV infection is a risk factor for metabolic abnormalities and cardiovascular disease [30] . Antiretroviral drugs may play an additional role in the occurrence of these conditions, as shown by the risk for myocardial infarction conveyed by the exposure to protease inhibitors [31] . Research has recently focused on the role of HIV infection itself, treated or not, since inflammation and T-cell/monocyte activation have been associated with pre-clinical and clinical cardiovascular endpoints [30, 32] . Untreated HIV infection leads to an unfavorable lipid profile [33] and we have shown that immune deficiency in treatment-naïve patients is associated with insulin resistance [29] . Since vitamin D insufficiency has been associated with metabolic abnormalities, inflammation, and pre-clinical markers of atherosclerosis in both the general and HIV-infected populations, we explored the relations between 25(OH)D levels and body composition, metabolic, immunologic, and inflammatory markers in recently diagnosed antiretroviral-naïve HIV-infected patients.
25(OH)D Low Levels in Black and White Patients
Vitamin D insufficiency, deficiency, and severe deficiency, were frequent in this population of antiretroviral-naïve patients (found in 93%, 67% and 24% of cases, respectively). Low 25(OH) levels were associated with smoking in the multivariate analysis, as previously reported [34] . The 25(OH)D concentration was much lower in Black than in White persons. Interestingly, while the expected association between the level of 25(OH)D and the season of sampling was confirmed in Black as well as White patients, seasonal variation was much less pronounced in Black persons. Since it is not known whether the influence of a low 25(OH)D level on cell functions and blood markers is short-or mid/long-term, this could put Black persons at a higher risk of deleterious consequences of vitamin D deficiency, because smaller variations around the year reduce the probability of reaching desirable 25(OH)D levels. Association of Severe Vitamin D Deficiency Levels with Low CD4 Counts and Inflammation
We confirm an inverse relation between 25(OH)D levels and immunodeficiency [12] , with the proportion of persons with a CD4 count below 100/mm 3 being higher in persons with 25(OH)D,10 ng/mL. This finding, in a population where there is no influence of antiretrovirals on the CD4 level, could be explained by the role played by the vitamin D/vitamin D receptor system in activation and TCR signaling in naive T cells [16] , and fits well with data showing that vitamin D deficiency is associated with clinical progression of untreated [17] or treated [18, 19] HIV disease, including AIDS-defining events [18] , and with a poorer CD4 restoration on treatment [20, 21] .
The strength and significance of the association between CD4,100/mm 3 and 25 OHD,10 ng/mL were reduced after adjustment on sTNFR or hsCRP level. It is therefore possible to hypothesize that the association between severe vitamin D deficiency and immune deficiency may be mediated by uncontrolled inflammation, which should be tested in intervention trials.
Indeed, in patients with very low 25(OH)D levels, we found higher levels of the inflammatory marker hsCRP, and of resistin, which is also considered as an inflammatory marker in human, in addition to its promoting role on insulin resistance and cardiovascular diseases [35] . Very low 25 OHD levels at inclusion in the cohort were also associated with higher levels of hsCRP and sTNFR1 after one year of follow-up without treatment. Interestingly these associations were not found in patients with vitamin D deficiency (25(OH)D,20 ng/mL), which suggests a threshold effect rather than a dose-response curve.
Vitamin D deficiency has already been associated with higher levels of inflammatory markers in different conditions (patients at a high cardiovascular risk or with arthritis, older persons) [6, 13] . In placebo-controlled studies, vitamin D supplementation has been shown to lower the level of the inflammatory cytokine TNF-a and to increase the level of the anti-inflammatory cytokine IL-10, in patients with heart insufficiency [14] , and to lower markers of inflammation and immune cell activation in tuberculosis [36] . Since cross-sectional studies such as the one presented here do not allow any conclusion on the temporality or causality of the relationships, the impact of vitamin D status on pro-inflammatory markers in HIV infection should be further studied, in intervention trials.
25(OH)D, Lipids and Insulin Resistance
We found no association between triglyceride levels, cholesterol or its fractions, glycemia, insulinemia, and severe vitamin D deficiency (,10 ng/mL) or deficiency (,20 ng/mL). Previous cross-sectional studies showed an inverse relation between vitamin D levels and lipids, but intervention studies have given divergent results regarding the effect of vitamin D supplementation on serum lipids [37] .
A previously published study, involving mainly Caucasian patients treated with antiretrovirals, found a correlation between low 25(OH)D and high insulin levels, but not lipoatrophy or hypoadiponectinemia [24] . In contrast, in this antiretroviral-naïve study population, we found no significant relation between 25(OH)D and fasting insulinemia. Antiretroviral drugs and their metabolic side effects could explain this discrepancy.
25(OH)D, Body Composition and Adipokines
In patients with 25(OH)D,10 ng/mL, we observed lower values of VAT, while there was no association with BMI, leptin or adiponectin. On the other hand, patients with 25(OH)D levels in the deficient range (,20 ng/mL) had significantly higher blood leptin.
Vitamin D, being liposoluble, can be trapped in adipose tissue, explaining why obesity is associated with low 25(OH)D levels, which transiently increase after bariatric surgery, probably reflecting 25(OH)D release during weight loss [38] . On the other hand, severe malnutrition can be associated with low 25(OH)D. In the setting of HIV infection, a study, in mostly treated patients, showed a trend towards lower 25(OH)D levels in persons both in the lower and higher BMI tertiles [18] . Thus, the relationships between vitamin D levels, fat mass and adipokine production are probably complex and dynamic: 1-25(OH) 2 D has been shown to attenuate adiponectin production [39] , and to suppress leptin secretion [40] in cultured human adipocytes, while leptin has been shown to stimulate fibroblast growth factor 23 expression and to suppress 1a-hydroxylation of vitamin D in a murine model [41] . This network of interactions may explain why no straightforward relationship was observed between 25(OH)D and adiposity or adipokine levels in this cross-sectional of HIV-infected persons, in whom ongoing inflammation also probably interferes with adipocyte functions.
25(OH)D and Renal Function
We found a trend towards an inverse association between 25(OH)D levels and MDRD-estimated GFR in treatment-naïve patients. This finding has been previously reported in HIVinfected patients, but a large majority was treated with antiretrovirals [11, 34] . In a setting where there is no influence of antiretrovirals on kidney function, this intriguing finding could be related to a recently described effect of vitamin D receptor activation, which was shown to increase the production of creatinine, without modification of its clearance [42] .
Strengths and Limitations of This Study
This is the first study assessing the association between 25(OH)D concentration and a panel of immunologic and metabolic markers, in a large group of recently diagnosed treatment-naïve persons living with HIV. In previous studies on vitamin D and HIV infection, a large majority of patients were receiving antiretroviral therapy, which could modify vitamin D metabolism, either directly, through the inhibition or activation of hydroxylation enzymes (protease inhibitors, efavirenz) [12] , or undirectly, through the impact on proximal tubular function (tenofovir) [43] . Treatment of HIV infection also results in immune restoration, and, to a certain extent, in the control of inflammation, while antiretroviral treatment may interfere with lipid/glucose metabolism, kidney and adipocyte physiology.
A limitation of observational studies such as the present one is that normal or desirable values for 25(OH)D are a controversial issue, particularly when examining nonskeletal markers [4] . Severe vitamin D deficiency (25(OH)D,10 ng/mL) has been associated with a poorer clinical evolution of HIV infection in a previous study that showed a clear that different threshold 25(OH)D levels could be associated with different biological markers or clinical endpoints. Lastly, this cross-sectional analysis does not allow to conclude on the direction and causality of the observed relationships.
Conclusion
In the absence of antiretroviral treatment, vitamin D deficiency was highly prevalent in White and Black HIV-infected patients living in France. In this population, low 25(OH)D was associated with smoking, with lower CD4 counts and higher inflammatory markers. We also found that the influence of season on vitamin D status was different in Black and White persons and that the level of the inflammatory marker sTNFR2 was associated with severe vitamin D deficiency only in Black persons. This could reflect differences in body composition, in the allelic distribution of genes related to vitamin D metabolism [44] or in the sensitivity to vitamin D [45] . This difference should be taken into account in future studies.
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